Provided by Tiger Trade Technology Pte. Ltd.

JPMORGAN HEALTHCARE LEADERS ETF

64.17
-0.0795-0.12%
Post-market: 64.06-0.1119-0.17%16:10 EDT
Volume:1K
Turnover:64.39K
Market Cap:9.63M
PE:- -
High:64.17
Open:63.85
Low:63.85
Close:64.25
52wk High:64.56
52wk Low:50.34
Shares:150.00K
Float Shares:150.00K
Volume Ratio:6.30
T/O Rate:0.67%
Dividend:0.51
Dividend Rate:0.80%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Moderna Vaccine Cuts Recurrence and Spread of High-Risk Melanoma, Raising New Treatment Hope

Reuters
·
Aug 19

Merck Shares Rise 1.9% Premarket

THOMSON REUTERS
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Safety Profiles of Intismeran and Keytruda in Trial were Consistent with Prior Reported Studies for the Combination

THOMSON REUTERS
·
Aug 19

Merck: Phase 3 Interpath-001 Trial of Intismeran Autogene Plus Keytruda Met Primary Endpoint of Recurrence Free Survival

THOMSON REUTERS
·
Aug 19

Merck: Co, Moderna Announce Positive Results from Phase 3 Interpath-001 Trial for Patients with Completely Resected Stage Iib-Iv Melanoma

THOMSON REUTERS
·
Aug 19

Merck: Co, Moderna Will Engage with Regulators on Filing Submissions for Intismeran Autogene in Combination with Keytruda

THOMSON REUTERS
·
Aug 19

Novo Begins Study to Find Lowest Effective Dose for Wegovy Pill

Reuters
·
Aug 19

The Key to Pharma M&A: Never Shopping Hungry - Heard on the Street

Dow Jones
·
Aug 19

Patent Cliffs Drive Pharma Expansion as Biotech M&A and IPO Markets Stage a Comeback

Stock News
·
Aug 19

Jefferies Reaffirms Their Hold Rating on Merck KGaA (0O14)

TIPRANKS
·
Aug 19

What This Top Biotech Fund is Buying Now

Dow Jones
·
Aug 19

Percheron Therapeutics Files ASX Corporate Governance Statement and Appendix 4G

TIPRANKS
·
Aug 19

Big Food is Fighting to Tempt Taste Buds in the Era of Weight-Loss Drugs

Dow Jones
·
Aug 19

J&J EVP Jennifer Taubert Disposes of 15,000 Common Shares for $3.95 Million

Reuters
·
Aug 19

Health Care up on Defensive Bias - Health Care Roundup

Dow Jones
·
Aug 19